# Randomized Clinical Trial in Parkinson's Disease Patients Using Pluripotent Adipose Stem Cells (PASCs)

> **NCT06141317** · PHASE1,PHASE2 · UNKNOWN · sponsor: **ClusterXStem-Costa Rica** · enrollment: 40 (actual)

## Conditions studied

- Parkinson Disease

## Interventions

- **BIOLOGICAL:** PASC transplantation (25 million PASCs/patient)
- **BIOLOGICAL:** Control

## Key facts

- **NCT ID:** NCT06141317
- **Lead sponsor:** ClusterXStem-Costa Rica
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-06-23
- **Primary completion:** 2024-09-01
- **Final completion:** 2024-11-01
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2023-12-01

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06141317

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06141317, "Randomized Clinical Trial in Parkinson's Disease Patients Using Pluripotent Adipose Stem Cells (PASCs)". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT06141317. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*